MediumCardiologyHeart failure with reduced ejection fractionca-mccqe1ca-rcpsc-im
A 58-year-old man with heart failure with reduced ejection fraction (LVEF 30%) remains NYHA class II despite optimal doses of an ACE inhibitor and a beta-blocker. According to contemporary Canadian heart failure guidelines, which addition best reflects the recommended foundational pharmacologic regimen?